<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <introducedDate>2019-06-21</introducedDate>
    <committeeReports />
    <textVersions>
      <item>
        <date>2019-06-21T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr3415ih/xml/BILLS-116hr3415ih.xml</url>
          </item>
        </formats>
        <type>Introduced in House</type>
      </item>
    </textVersions>
    <amendments />
    <notes />
    <updateDate>2019-10-31T16:00:29Z</updateDate>
    <billNumber>3415</billNumber>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 165, Number 105 (Friday, June 21, 2019)][House]From the Congressional Record Online through the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]By Ms. SLOTKIN:H.R. 3415.Congress has the power to enact this legislation pursuantto the following:The Congress shall have Power . . . To make all Laws whichshall be necessary and proper for carrying into Execution theforegoing Powers, and all other Powers vested by thisConstitution in the Government of the United States, or inany Department or Officer thereof.[[Page H5038]][Page H5037]</pre>]]></constitutionalAuthorityStatementText>
    <calendarNumbers />
    <version>1.0.0</version>
    <sponsors>
      <item>
        <middleName />
        <party>D</party>
        <fullName>Rep. Slotkin, Elissa [D-MI-8]</fullName>
        <byRequestType />
        <bioguideId>S001208</bioguideId>
        <firstName>Elissa</firstName>
        <identifiers>
          <lisID>2407</lisID>
          <bioguideId>S001208</bioguideId>
          <gpoId />
        </identifiers>
        <lastName>Slotkin</lastName>
        <district>8</district>
        <state>MI</state>
      </item>
    </sponsors>
    <createDate>2019-06-22T16:12:21Z</createDate>
    <titles>
      <item>
        <title>To amend title XVIII of the Social Security Act to require prescription drug plan sponsors to include real-time benefit information as part of such sponsor's electronic prescription program under the Medicare program.</title>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
      </item>
      <item>
        <title>Real-Time Beneficiary Drug Cost Bill</title>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
      </item>
      <item>
        <title>Real-Time Beneficiary Drug Cost Bill</title>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>Display Title</titleType>
      </item>
      <item>
        <title>Real-Time Beneficiary Drug Cost Bill</title>
        <chamberName />
        <chamberCode />
        <parentTitleType />
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
      </item>
    </titles>
    <laws />
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Health care costs and insurance</name>
          </item>
          <item>
            <name>Health care coverage and access</name>
          </item>
          <item>
            <name>Health information and medical records</name>
          </item>
          <item>
            <name>Health personnel</name>
          </item>
          <item>
            <name>Medicare</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
      <actionTypeCounts>
        <introducedInTheHouse>1</introducedInTheHouse>
        <billReferrals>2</billReferrals>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
      <item>
        <links />
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <committee>
          <systemCode>hswm00</systemCode>
          <name>Ways and Means Committee</name>
        </committee>
        <actionCode>H11100</actionCode>
        <actionDate>2019-06-21</actionDate>
      </item>
      <item>
        <links />
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <actionCode>H11100</actionCode>
        <actionDate>2019-06-21</actionDate>
      </item>
      <item>
        <links />
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <committee />
        <actionCode>Intro-H</actionCode>
        <actionDate>2019-06-21</actionDate>
      </item>
      <item>
        <links />
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <committee />
        <actionCode>1000</actionCode>
        <actionDate>2019-06-21</actionDate>
      </item>
    </actions>
    <title>Real-Time Beneficiary Drug Cost Bill</title>
    <originChamber>House</originChamber>
    <committees>
      <billCommittees>
        <item>
          <systemCode>hswm00</systemCode>
          <activities>
            <item>
              <date>2019-06-21T13:03:10Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <type>Standing</type>
          <subcommittees />
          <chamber>House</chamber>
          <name>Ways and Means Committee</name>
        </item>
        <item>
          <systemCode>hsif00</systemCode>
          <activities>
            <item>
              <date>2019-06-21T13:03:05Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <type>Standing</type>
          <subcommittees />
          <chamber>House</chamber>
          <name>Energy and Commerce Committee</name>
        </item>
      </billCommittees>
    </committees>
    <billType>HR</billType>
    <cosponsors>
      <item>
        <bioguideId>A000375</bioguideId>
        <district>19</district>
        <sponsorshipDate>2019-06-21</sponsorshipDate>
        <firstName>Jodey</firstName>
        <lastName>Arrington</lastName>
        <state>TX</state>
        <party>R</party>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Rep. Arrington, Jodey C. [R-TX-19]</fullName>
        <identifiers>
          <lisID>2350</lisID>
          <gpoId />
          <bioguideId>A000375</bioguideId>
        </identifiers>
        <middleName>C.</middleName>
      </item>
      <item>
        <bioguideId>K000380</bioguideId>
        <district>5</district>
        <sponsorshipDate>2019-09-11</sponsorshipDate>
        <firstName>Daniel</firstName>
        <lastName>Kildee</lastName>
        <state>MI</state>
        <party>D</party>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Rep. Kildee, Daniel T. [D-MI-5]</fullName>
        <identifiers>
          <gpoId />
          <lisID>2134</lisID>
          <bioguideId>K000380</bioguideId>
        </identifiers>
        <middleName>T.</middleName>
      </item>
      <item>
        <bioguideId>S001209</bioguideId>
        <district>7</district>
        <sponsorshipDate>2019-09-11</sponsorshipDate>
        <firstName>Abigail</firstName>
        <lastName>Spanberger</lastName>
        <state>VA</state>
        <party>D</party>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <fullName>Rep. Spanberger, Abigail Davis [D-VA-7]</fullName>
        <identifiers>
          <lisID>2456</lisID>
          <bioguideId>S001209</bioguideId>
          <gpoId />
        </identifiers>
        <middleName>Davis</middleName>
      </item>
    </cosponsors>
    <relatedBills>
      <item>
        <latestAction>
          <text>Received in the Senate and Read twice and referred to the Committee on Finance.</text>
          <actionDate>2019-10-29</actionDate>
        </latestAction>
        <type>HR</type>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <latestTitle>Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act</latestTitle>
        <number>2115</number>
        <congress>116</congress>
      </item>
      <item>
        <latestAction>
          <text>Placed on the Union Calendar, Calendar No. 170.</text>
          <actionDate>2019-09-24</actionDate>
        </latestAction>
        <type>HR</type>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <latestTitle>More Efficient Tools to Realize Information for Consumers Act</latestTitle>
        <number>2296</number>
        <congress>116</congress>
      </item>
      <item>
        <latestAction>
          <text>Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 41 - 0.</text>
          <actionDate>2019-06-26</actionDate>
        </latestAction>
        <type>HR</type>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <latestTitle>Beneficiary Education Tools, Telehealth, and Extenders Reauthorization Act of2019</latestTitle>
        <number>3417</number>
        <congress>116</congress>
      </item>
      <item>
        <latestAction>
          <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
          <actionDate>2019-06-21</actionDate>
        </latestAction>
        <type>HR</type>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <latestTitle>Shop Rx Act of 2019</latestTitle>
        <number>3408</number>
        <congress>116</congress>
      </item>
    </relatedBills>
    <recordedVotes />
    <policyArea>
      <name>Health</name>
    </policyArea>
    <congress>116</congress>
    <latestAction>
      <actionDate>2019-06-21</actionDate>
      <links />
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </latestAction>
    <cboCostEstimates />
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2019-06-21</actionDate>
          <lastSummaryUpdateDate>2019-07-06T13:54:48Z</lastSummaryUpdateDate>
          <actionDesc>Introduced in House</actionDesc>
          <text><![CDATA[<p><b>Real-Time Beneficiary Drug Cost Bill</b></p> <p>This bill provides statutory authority for certain provisions of the Centers for Medicare &amp; Medicaid Services rule titled &quot;Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses,&quot; published on May 23, 2019. The rule requires, in part, Medicare prescription drug plan sponsors to implement an electronic, real-time benefit tool that is capable of integrating with at least one prescriber's electronic prescribing system or electronic health record. The tool must provide prescribers with patient-specific, real-time formulary and benefit information, including information regarding cost-sharing, formulary alternatives, and utilization management requirements. The rule takes effect January 1, 2021. </p>]]></text>
          <name>Introduced in House</name>
          <updateDate>2019-06-21T04:00:00Z</updateDate>
        </item>
      </billSummaries>
    </summaries>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

